Chen, Jingbiao
Xu, Peng
Kalutkiewicz, Kyle
Sheng, Yiyang
Warsame, Fatima
Tahboub-Amawi, Mahmoud-Adam
Li, Jiahui
Wang, Jin
Venkatesh, Sudhakar K.
Ehman, Richard L.
Shah, Vijay H.
Simonetto, Douglas A.
Yin, Meng http://orcid.org/0000-0001-6778-192X
Funding for this research was provided by:
Foundation for the National Institutes of Health (UH2/3 AA026887, R37 EB001981, R01 EB017197, R01 DK132718)
Article History
Received: 20 May 2024
Revised: 27 June 2024
Accepted: 28 June 2024
First Online: 18 July 2024
Declarations
:
: <i>Kyle Kalutkiewicz</i> is employed by and consults for Resoundant, Inc. <i>Richard L. Ehman</i> is CEO of Resoundant. <i>Richard L. Ehman</i> and <i>Meng Yin</i> have Intellectual property rights with Mayo Clinic and own stock in Resoundant, Inc. The remaining authors have no conflicts to report.